Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mayumi Kaneta is active.

Publication


Featured researches published by Mayumi Kaneta.


Biochemical and Biophysical Research Communications | 1988

A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line

Satoru Nakai; Keiko Mizuno; Mayumi Kaneta; Yoshikatsu Hirai

Interleukin-1 (IL-1) exhibits multiple biological properties on various tissues by modulating immunologic, inflammatory, metabolic, and neurologic functions. Considerable attention has focussed on the measurement of IL-1 activity. We reported a simple, sensitive, and specific bioassay for IL-1 using human melanoma A375 subclone which is highly sensitive for the cell growth inhibitory activity of IL-1. This bioassay method is allows detection of as low as 10pg of IL-1 beta/ml or 30pg of IL-1 alpha/ml. Since this A375 subclone cell dose not respond to prostaglandin E2 plant lectins, lipopolysaccharide, and cytokines such as interleukin-2, interleukin-6, tumor necrosis factor, interferon or colony-stimulating factor, it is an extremely useful and rapid method for the measurement of IL-1 activity in a variety of experimental and clinical conditions. The assay method was used in the presence of antisera to IL-1 beta to discriminate two species of IL-1, IL-1 alpha and IL-1 beta, produced in human peripheral mononuclear cells.


Archive | 1985

Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1987

IL-1 beta derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1987

IL-1alpha derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Sanraunjihausu Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1989

IL-1alpha derivates and medicament for treating thrombocytopenia.

Yoshikatsu Hirai; Satoru Nakai; Koutoku Aihara; Kazuyoshi Kawai; Mayumi Kaneta; Takashi Kamogashira; Yoshihiro Masui


Archive | 1987

IL-1α derivatives and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1993

Medical uses of IL-1 beta.

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Haitsu Soreiyu Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1995

Methods of use of IL-1α

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1987

IL-1β and derivatives thereof and drugs

Satoru Nakai; Mayumi Kaneta; Yoshikazu Kikumoto; Yeong-Man Hong; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai


Archive | 1997

INTERLUKIN-1-BETA DERIVS, CODING DNA, VECTOR, TRANSFORMANT AND PHARMACEUTICAL COMPOSITIONS

Satoru Nakai; Mayumi Kaneta; Hong Young-Man; Kazuyoshi Kawai; Setsuko Takegata; Kiyoshi Ishii; Yasuo Yanagihara; Yoshikatsu Hirai; Yoshikatzu Kikumoto

Collaboration


Dive into the Mayumi Kaneta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge